Addex Therapeutics (ADXN) Institutional Ownership $9.52 +0.14 (+1.49%) As of 11:53 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Addex Therapeutics (NASDAQ:ADXN)CurrentInstitutional OwnershipPercentage16.14%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$141.41KNumber ofInstitutional Sellers(last 12 months)0 Get ADXN Insider Trade Alerts Want to know when executives and insiders are buying or selling Addex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ADXN Institutional Buying and Selling by Quarter Addex Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/7/2025GAMMA Investing LLC8,757$64K0.0%+766.2%0.826% 2/17/2025Citadel Advisors LLC12,079$85K0.0%N/A1.140% 2/13/2024Armistice Capital LLC43,000$260K0.0%-92.0%4.343% 11/15/2023Armistice Capital LLC537,000$206K0.0%+103.4%65.328% 5/1/2023Virtu Financial LLC42,912$41K0.0%+203.8%0.334% 2/14/2023Susquehanna International Group LLP72,142$45K0.0%N/A0.561% 2/10/2023NEA Management Company LLC1,080,000$113K0.0%-80.9%8.398% 11/14/2022Armistice Capital LLC320,000$256K0.0%+26.5%2.941% 11/14/2022NEA Management Company LLC5,648,690$830K0.0%+500.0%51.923% 8/5/2022OLD Mission Capital LLC31,134$36K0.0%N/A0.286% 8/12/2021New Leaf Venture Partners L.L.C.50,000$478K0.1%N/A0.609% 8/2/2021NEA Management Company LLC180,000$17.21M0.2%N/A2.192% 5/21/2021Citadel Advisors LLC11,604$121K0.0%N/A0.141% 5/18/2021Citadel Advisors LLC11,604$121K0.0%N/A0.212% 5/12/2021UBS Group AG2,520$26K0.0%+2,420.0%0.046% (Data available from 1/1/2016 forward) ADXN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ADXN shares? During the previous two years, the following institutional investors and hedge funds held shares of Addex Therapeutics shares: Armistice Capital LLC ($260K), and Citadel Advisors LLC ($85K), GAMMA Investing LLC ($64K).Learn more on Addex Therapeutics' institutional investors. What percentage of Addex Therapeutics' stock is owned by institutional investors? 16.14% of Addex Therapeutics' stock is owned by institutional investors. Learn more on ADXN's institutional investor holdings. Which institutional investors have been buying Addex Therapeutics' stock? The following institutional investors have purchased Addex Therapeutics' stock in the last 24 months: Armistice Capital LLC ($273K), Citadel Advisors LLC ($12.08K), and GAMMA Investing LLC ($7.75K). How much institutional buying is happening at Addex Therapeutics? Institutional investors have bought a total of 19,825 shares in the last 24 months. This purchase volume represents approximately $141.41K in transactions. Related Companies Karyopharm Therapeutics Major Shareholders Eagle Pharmaceuticals Major Shareholders Acrivon Therapeutics Major Shareholders PepGen Major Shareholders Exicure Major Shareholders Barinthus Biotherapeutics Major Shareholders Mersana Therapeutics Major Shareholders Artiva Biotherapeutics Major Shareholders Eliem Therapeutics Major Shareholders Xilio Therapeutics Major Shareholders This page (NASDAQ:ADXN) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Addex Therapeutics Ltd. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Addex Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADXN Stock Alerts